Navigation Links
Thrombosis, a Serious Risk in Children with Leukemia

Thrombosis is a serious complication that can occur in children affected by acute lymphoblastic leukemia and can in turn lead to heart attack, pulmonary embolism and other cardiovascular diseases//.

It is the result of a research performed in Italy by the Laboratory of Genetic and Environmental Epidemiology and the Onco-Haematology Unit of the Catholic University in collaboration with the Haematology Division of the University of L'Aquila.

Thrombosis in children with leukaemia is a serious problem, that adds a new clinical concern for these children already troubled by such a severe disease. Prevention and focused therapy are essential in order to avoid complications that may turn out to be extremely harsh. What is the frequency with which thrombosis occurs in these young patients? Which role do their genetic characteristics play and which kind of therapy are they submitted to? The study used metanalytic techniques, a complex statistic procedure that, by combining and analysing data published by several international research teams, allowed the researchers to determine in a very precise way the association between ALL and thrombotic complications in 1,752 children affected by this type of leukaemia.

Data were taken from 17 international studies selected according to strict scientific criteria. In 5,2 percent of the children thrombotic complications were reported. Researchers have been able to identify several factors involved in determining the risk for this complication. Particularly, many of the thrombotic events occurred during the so called 'induction' phase of the antileukaemic therapy. Moreover, the researchers successfully identified therapies and medical procedures mainly associated with the risk of thrombosis. Finally, the possible role of genetic determinants (especially the hereditary tendency for excessive blood coagulation, called thrombophilia) was explored.

"The risk of these complications – says Maria Benedet ta Donati, Scientific Projects Coordinator at the Research Laboratories of the Catholic University - is relatively high and the analysis of the affected children's characteristics allowed us to identify those at high risk. In this way, data will be immediately available for haematologists in order to decide the best therapies to undertake, also according to the genetic predisposition of each individual child".

Source: Eurekaler
'"/>




Related medicine news :

1. Socialization A Serious Trouble For Childhood Cancer Survivors
2. Viagra May Be Useful For Serious Lung Disease
3. Mountain Biking Results In Serious Injuries
4. Breast Cancer More Serious For Younger Patients
5. Rahul Mahajans Condition Is Serious But Stable : Hospital
6. Africans Should Take Their Traditional Medicine Very Seriously
7. Electronic Patient Record "Serious Threat" to Patient Confidentiality
8. "Serious Failings" Led To Spread Of Lethal Hospital Bug
9. Scottish Children Attracted To Serious Gambling
10. Government Views Cola Contamination with Utmost Seriousness: Anbumani
11. Callous Thieves Rob An Seriously Ill Child Of His Vital Heart Machine
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:9/20/2017)... ... ... “The Trials I Face to Receive God’s Grace”: a mesmerizing take ... goals to better one’s life through God. “The Trials I Face to Receive God’s ... wrong places, found a love for writing. Green feels that expressing his feelings through ...
(Date:9/20/2017)... ... ... Houston, Texas, investment firm CORDA Investment Management, LLC, believes in giving back. ... work and rolled up their sleeves to help with relief efforts. The team picked ... process of rebuilding. , CORDA founder Bonner C. Barnes notes that investment management firms ...
(Date:9/20/2017)... ... September 20, 2017 , ... “The Foggy Road to Moorwick”: the adventures of a young ... creation of published author, Jeanine Liston, a busy mother of five who used her time ... been writing this book for over twenty years. It was a way to give ...
(Date:9/20/2017)... (PRWEB) , ... September 20, 2017 , ... “Monique”: ... into uncomfortable situations. “Monique” is the creation of published author, Colleen Crispi, has owned ... Since then Crispi has been involved in real estate and cooking. , “The ...
(Date:9/19/2017)... ... September 19, 2017 , ... DeSola Group, ... marketing leader, Denise Flannery, to its strategic advisory and client development team. ... will work with clients across different industries to develop and implement market-justified strategies, ...
Breaking Medicine News(10 mins):
(Date:9/9/2017)... 9, 2017  Eli Lilly and Company (NYSE: ... endpoint data for lasmiditan, an investigational, oral, first-in-class molecule ... significant improvements compared to placebo in the Phase 3 ... the 18th Congress of the International Headache Society (IHC) ... data presented today demonstrate lasmiditan,s potential to reduce pain ...
(Date:9/7/2017)... Caris Life Sciences, a leading innovator ... of precision medicine, today announced results from two ... molecular profiling approach in guiding therapeutic strategies in ... (CGP+) with Caris Molecular Intelligence ® to ... level, leading to more therapeutic options and improved ...
(Date:9/7/2017)... , Sept. 7, 2017   BioLife Solutions , Inc. ... marketer of proprietary clinical grade cell and tissue hypothermic ... that Mike Rice , President and CEO, will be ... Rodman & Renshaw 19 th Annual Global ... time (12:25 p.m. Pacific time). The conference is being held ...
Breaking Medicine Technology: